Compare, Analyse Suven Life Sciences with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
ACTAVIS
Dec-18
SUVEN LIFE SCIENCES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs33814,220-   
Low Rs1699,539-   
Sales per share (Unadj.) Rs52.13,488.2-  
Earnings per share (Unadj.) Rs6.8-1,123.6-  
Cash flow per share (Unadj.) Rs8.6367.6-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.314,387.3-  
Shares outstanding (eoy) m127.28332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.93.4 142.8%   
Avg P/E ratio x37.1-10.6 -351.1%  
P/CF ratio (eoy) x29.632.3 91.5%  
Price / Book Value ratio x3.90.8 470.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2723,951,174 0.8%   
No. of employees `0001.116.9 6.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.268,650.1 8.9%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5-22,112.2 -3.6%   
INCOME DATA
Net Sales Rs m6,6351,160,187 0.6%  
Other income Rs m24222,187 1.1%   
Total revenues Rs m6,8771,182,373 0.6%   
Gross profit Rs m1,60430,403 5.3%  
Depreciation Rs m221495,955 0.0%   
Interest Rs m3866,949 0.1%   
Profit before tax Rs m1,587-510,315 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,151 0.0%   
Tax Rs m718-6,467 -11.1%   
Profit after tax Rs m869-373,697 -0.2%  
Gross profit margin %24.22.6 922.6%  
Effective tax rate %45.21.3 3,569.1%   
Net profit margin %13.1-32.2 -40.7%  
BALANCE SHEET DATA
Current assets Rs m6,232475,848 1.3%   
Current liabilities Rs m1,490420,951 0.4%   
Net working cap to sales %71.54.7 1,510.5%  
Current ratio x4.21.1 370.0%  
Inventory Days Days8620 441.3%  
Debtors Days Days8366 124.6%  
Net fixed assets Rs m4,043131,327 3.1%   
Share capital Rs m1270-   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3104,785,228 0.2%   
Long term debt Rs m181,685,052 0.0%   
Total assets Rs m10,3897,480,400 0.1%  
Interest coverage x43.1-6.6 -650.9%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.2 411.8%   
Return on assets %8.7-4.1 -212.9%  
Return on equity %10.5-7.8 -134.0%  
Return on capital %19.5-4.8 -403.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356414,491 0.1%  
From Investments Rs m-279227,709 -0.1%  
From Financial Activity Rs m-225-711,391 0.0%  
Net Cashflow Rs m-148-68,845 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare SUVEN LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: UNICHEM LAB  PFIZER  ABBOTT INDIA  STERLING BIOTECH  DR. DATSONS LABS  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market (Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFE SCIENCES SHARE PRICE


May 14, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - ALKEM LABORATORIES COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS